Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Duration: March 1, 2019
to
present
General Issues: Health Issues , Medicare/Medicaid , Veterans , Taxation/Internal Revenue Code
Spending: about $1,230,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2019: U.S. Senate, House of Representatives, Veterans Affairs - Dept of (VA), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), Vice President of the U.S.
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Chris Jones Chief of Staff, Rep. Mike Ferguson; 2001-2009; Deputy Chief of Staff, Rep. David McIntosh, 1995-2001; Communications Director, House Government Reform and Oversight Subcommittee, 1996-2001; Press Secretary, Rep. John Myers, 1994-1995.
Chief of Staff, Rep. Mike Ferguson, 2001-2009; Deputy Chief of Staff, Rep. David McIntosh, 1995-2001; Communications Director, House Government Reform and Oversight Subcommittee, 1996-2001; Press Secretary, Rep. John Myers, 1994-1995.
Adam Higgins Legislative Assistant, Rep. Mike Ferguson, 2007-2008.
Tyler Thompson Legislative Assistant, Sen. Johnny Isakson, 2005-2012; Legislative Correspondent, Sen. Saxby Chambliss, 2005-2005; Legislative Correspondent, Sen. Zell Miller, 2002-2005.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on April 20.
Original Filing: 301568236.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
4th Quarter, 2023
In Q4, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on Jan. 22.
Original Filing: 301535919.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
3rd Quarter, 2023
In Q3, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on Oct. 17, 2023.
Original Filing: 301502558.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
2nd Quarter, 2023
In Q2, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on July 19, 2023.
Original Filing: 301481834.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
1st Quarter, 2023
In Q1, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on April 20, 2023.
Original Filing: 301461237.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
4th Quarter, 2022
In Q4, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on Jan. 19, 2023.
Original Filing: 301435566.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on Oct. 20, 2022.
Original Filing: 301416062.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on July 18, 2022.
Original Filing: 301384249.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on April 15, 2022.
Original Filing: 301356651.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on Jan. 15, 2022.
Original Filing: 301323157.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on Oct. 18, 2021.
Original Filing: 301302515.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on July 16, 2021.
Original Filing: 301278127.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on April 17, 2021.
Original Filing: 301255169.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on Jan. 15, 2021.
Original Filing: 301232051.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on Oct. 19, 2020.
Original Filing: 301216818.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on July 12, 2020.
Original Filing: 301187006.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on April 18, 2020.
Original Filing: 301171522.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
H.R. 3, the Lower Drug Costs Now Act.
H.R. 19, the Lower Costs, More Cures Act.
H.R. 1393, the Medicare Dental, Vision, and Hearing Benefit Act.
H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting.
H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting.
H.R. 3975, the Contact Lens Prescription Verification Modernization Act.
H.R. 3762, the Dental and Optometric Care Access Act.
H.R. 4665, the Medicare Vision Act.
S. 1423, the Medicare and Medicaid Dental, Vision, and Hearing Benefit Act.
S. 2543, the Prescription Drug Price Reduction Act.
S. 3129, the Lower Costs, More Cures Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
H.R.1393, the Medicare Dental, Vision, and Hearing Benefit Act.
H.R. 4665, the Medicare Vision Act.
S. 1423, the Medicare and Medicaid Dental, Vision, and Hearing Benefit Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on Jan. 18, 2020.
Original Filing: 301120986.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
H.R. 3, the Lower Drug Costs Now Act.
H.R. 19, the Lower Costs, More Cures Act.
H.R. 1393, the Medicare Dental, Vision, and Hearing Benefit Act.
H.R. 1865, the Further Consolidated Appropriations Act, 2020, specifically Section 501, repeal of the medical device excise tax.
H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting.
H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting.
H.R. 3975, the Contact Lens Prescription Verification Modernization Act.
H.R. 3762, the Dental and Optometric Care Access Act.
H.R. 4665, the Medicare Vision Act.
S. 1423, the Medicare and Medicaid Dental, Vision, and Hearing Benefit Act.
S. 2543, the Prescription Drug Price Reduction Act.
S. 3129, the Lower Costs, More Cures Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
H.R.1393, the Medicare Dental, Vision, and Hearing Benefit Act.
H.R. 4665, the Medicare Vision Act.
S. 1423, the Medicare and Medicaid Dental, Vision, and Hearing Benefit Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1865, the Further Consolidated Appropriations Act, 2020, specifically Section 501, repeal of the medical device excise tax.
H.R. 2207, the Protect Medical Innovation Act.
S. 692, the Protect Medical Innovation Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC , earning $60,000. The report was filed on Oct. 18, 2019.
Original Filing: 301070592.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies.
H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting.
H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting.
H.R. 3, the Lower Drug Costs Now Act.
S. 2543, the Prescription Drug Price Reduction Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 692, the Protect Medical Innovation Act
H.R. 2207, the Protect Medical Innovation Act
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, BAKER & HOSTETLER LLP lobbied for Alcon Vision, LLC formerly reported as Alcon Laboratories, Inc. , earning $60,000. The report was filed on July 21, 2019.
Original Filing: 301053824.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies;
H.R. 2113, the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, including medical device product samples reporting;
H.R. 2296, the FAIR Drug Pricing Act, including medical device product samples reporting
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 692, the Protect Medical Innovation Act
H.R. 2207, the Protect Medical Innovation Act
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Implementation issues relating to Public Law No. 113-146, the Veterans Access, Choice and Accountability Act, including provider reimbursement policies
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, BAKER & HOSTETLER LLP lobbied for Alcon Laboratories, Inc. , earning $30,000. The report was filed on April 18, 2019.
Original Filing: 301028596.xml
Lobbying Issues
Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Medicaid
Lobbying Issues
S. 692, the Protect Medical Innovation Act
H.R. 2207, the Protect Medical Innovation Act
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2019
Baker & Hostetler LLP filed a lobbying registration on March 5, 2019 to represent Alcon Laboratories, Inc., effective March 1, 2019.
Original Filing: 301021151.xml
Issue(s) they said they’d lobby about: Federal regulatory and reimbursement policies relating to eye care services, medicines and medical technologies .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...